Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

NCT02606851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2017-11-17

No results posted yet for this study

Summary

China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients with Gastroesophageal Reflux Disease

Conditions

  • Patients With Typical Symptoms of GERD (GERD Q >= 8)

Sponsors & Collaborators

Principal Investigators

  • Duowu Zou, leading PI · Changhai Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-04
Primary Completion
2016-12-28
Completion
2016-12-28

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02606851 on ClinicalTrials.gov